Zolbetuximab demonstrates favorable efficacy in the treatment of unresectable advanced recurrent gastric cancer positive for Claudin 18.2 (CLDN18.2). For many patients, whether zolbetuximab can be purchased in China has become a key concern. Currently, zolbetuximab has been launched in China but not included in China’s national medical insurance list, and patients can obtain this drug through domestic channels.
Is Zolbetuximab Available for Purchase in China?
Zolbetuximab has been officially launched in China. Patients can purchase the drug directly from domestic pharmacies or hospitals.
Overseas Drug Procurement Channels
Many patients choose to obtain zolbetuximab through overseas drug procurement. They can purchase the drug via foreign pharmacies, medical institutions, or professional drug purchasing services. However, overseas drug procurement is associated with multiple risks, such as unguaranteed drug quality and legal/regulatory restrictions. When opting for overseas drug procurement, patients should carefully select channels.
Participation in Clinical Trials
In China, the new drug application for zolbetuximab has been accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) and the drug has been officially launched. Patients can obtain zolbetuximab by participating in relevant clinical trials. Clinical trials not only provide patients with treatment opportunities but also help collect more data on the drug’s safety and efficacy.
Therapeutic Efficacy of Zolbetuximab
By binding to CLDN18.2, zolbetuximab inhibits the growth and spread of tumor cells, thereby prolonging patients’ survival and improving their quality of life.
Clinical Trial Data
Multiple sets of clinical trial data show that the combination regimen of zolbetuximab and chemotherapy can significantly improve patients’ progression-free survival (PFS) and overall survival (OS). In a clinical trial involving patients with advanced gastric cancer, patients receiving the zolbetuximab plus chemotherapy regimen had significantly prolonged survival compared with those receiving chemotherapy alone.
Patient Feedback
In addition to clinical trial data, patients’ actual treatment experience is also an important basis for evaluating the therapeutic efficacy of zolbetuximab. Many patients reported that after receiving zolbetuximab treatment, their symptoms were significantly relieved and their quality of life was improved.
Dietary Recommendations for Patients Taking Zolbetuximab
During medication, patients’ diet has an important impact on the drug’s efficacy and the body’s recovery. The following are some dietary recommendations for patients taking zolbetuximab:
Balanced Nutrition
Patients should maintain a balanced diet during medication and intake sufficient nutrients such as protein, carbohydrates, fats, vitamins, and minerals. These nutrients help enhance patients’ immunity and improve the body’s ability to resist diseases.
Light and Easy-to-Digest Foods
Since chemotherapy drugs may cause gastrointestinal reactions (e.g., nausea, vomiting), patients should choose light and easy-to-digest foods during medication. They should avoid overly greasy, spicy, or irritating foods to prevent increasing the burden on the gastrointestinal tract.
During medication, patients should maintain a balanced diet, choose light and easy-to-digest foods, and drink plenty of water to promote drug excretion and body recovery.
